⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27961451 | 0.85 | — | — | |
| SCHEMBL27950498 | 0.85 | — | — | |
| SCHEMBL153128 | 0.85 | — | — | |
| SCHEMBL80013 | 0.83 | — | — | |
| SCHEMBL9261328 | 0.81 | — | — | |
| SCHEMBL5263720 | 0.75 | — | — | |
| SCHEMBL195268 | 0.72 | — | — | |
| SCHEMBL6028390 | 0.72 | — | — | |
| SCHEMBL1526975 | 0.71 | — | — | |
| SCHEMBL845377 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024022481-A1 | PHENYL-SUBSTITUTED DIHYDRONAPHTHYRIDINE COMPOUNDS, AND PREPARATION AND USE THEREOF | 苏中药业集团股份有限公司 | 2024-02-01 | — | — | WO | claimed |
| US-20240025892-A1 | SALT INDUCIBLE KINASE INHIBITORS | THE GENERAL HOSPITAL CORPORATION | 2024-01-25 | — | — | US | claimed |
| EP-4192459-A1 | SALT INDUCIBLE KINASE INHIBITORS | The General Hospital Corporation (US) | 2023-06-14 | — | — | EP | claimed |
| CN-116234549-A | Salt-induced kinase inhibitors | 总医院公司 | 2023-06-06 | — | — | CN | claimed |
| WO-2023064152-A1 | TRICYCLIC SULFAMIDES AND SULTAMS | MERCK SHARP & DOHME LLC (US) | 2023-04-20 | — | — | WO | claimed |
| CN-115594673-A | Estrogen receptor modulators and uses thereof | 扬子江药业集团南京海陵药业有限公司（CN） | 2023-01-13 | — | — | CN | claimed |
| US-20220162193-A1 | PYRAZOLESULFONAMIDES AS ANTITUMOR AGENTS | PELOTON THERAPEUTICS, INC. (US) | 2022-05-26 | — | — | US | claimed |
| EP-3953331-A1 | PYRAZOLESULFONAMIDES AS ANTITUMOR AGENTS | Peloton Therapeutics, Inc. (US) | 2022-02-16 | — | — | EP | claimed |
| CN-113121393-A | Aromatic amide compound and application thereof in medicines | 广东东阳光药业有限公司 | 2021-07-16 | — | — | CN | claimed |
| US-20210206760-A1 | PHENYL-SUBSTITUTED DIHYDRONAPHTHYRIDINE COMPOUND AND USE THEREOF | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2021-07-08 | — | — | US | claimed |
| WO-2002067684-A1 | PYRIDYL PYRIMIDINES FOR USE AS PESTICIDES | BAYER CROPSCIENCE AG (DE) | 2002-09-06 | — | — | WO | claimed |
| EP-0364797-B1 | N-aryl-nitrogenated heterocycles, process for their preparation and their use as herbicides | BAYER AG (DE) | 1994-02-16 | — | — | EP | claimed |
| US-5221318-A | Crop plant selectivity | BAYER AKTIENGESELLSCHAFT (DE) | 1993-06-22 | — | — | US | claimed |
| US-5108483-A | HERBICIDAL 6-HETEROCYCLIC GROUP SUBSTITUTED BENZOXAZINES | BAYER AKTIENGESELLSCHAFT (DE) | 1992-04-28 | — | — | US | claimed |
| EP-0473387-A2 | Anti-fungal triazole derivatives, their preparation and uses | Sankyo Company Limited (JP) | 1992-03-04 | — | — | EP | claimed |
| US-5069711-A | PREEMERGENCE | BAYER AKTIENGESELLSCHAFT (DE) | 1991-12-03 | — | — | US | claimed |
| EP-0427031-A2 | N-aryl-nitrogen heterocycles | BAYER AG (DE) | 1991-05-15 | — | — | EP | claimed |
| EP-0416361-A1 | N-(5-alkyl thiophenyl)-nitrogenheterocycles | BAYER AG (DE) | 1991-03-13 | — | — | EP | claimed |
| EP-0400403-A2 | N-aryl-nitrogen-heterocycles | BAYER AG (DE) | 1990-12-05 | — | — | EP | claimed |
| EP-0364797-A2 | N-aryl-nitrogenated heterocycles, process for their preparation and their use as herbicides | BAYER AG (DE) | 1990-04-25 | — | — | EP | claimed |